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Purpose: To evaluate the efficacy of topical administration of 0.5%
povidone-iodine in experimental Fusarium solani keratitis in rabbits.
Methods: Fungal keratitis caused by Fusarium solani was induced in the
right eye of 24 New Zealand rabbits. The rabbits were randomly divided
into 3 different treatment groups: Group I (povidone-iodine) - treated with
topical 0.5% povidone-iodine; Group II (natamycin) - treated with topical
5% natamycin; and Group III (control) - treated with topical saline solution.
In all groups the rabbits were treated for three days and then sacrificed. The
corneas were excised, macerated and immersed in 10 mL BHI. Culture
samples were plated daily on Sabouraud’s agar for 7 days, and the number
of colony-forming units (CFU) was counted. The rabbits were clinically
evaluated during the treatment period. Results: The povidone-iodine and
natamycin groups demonstrated better efficacy than the control group
based on the number of rabbits with no colonies growing. However, there
were no statistically significant differences between the three groups
when the number of CFU was analyzed (p>0.05). Conclusion: Our study
demonstrates important methodological considerations in the use of in
vivo animal models for the testing of antifungal agents. Using this sample
size and methodology of counting CFU, topical 0.5% povidone-iodine
demonstrated no benefit in the treatment of experimental Fusarium solani
when compared with topical 5% natamycin.
ABSTRACT
INTRODUCTION
Among suppurative corneal ulcerations, fungal keratitis is responsible for
significant ocular morbidity and blindness, primarily in the developing world.
Its incidence is variable, but it is clearly higher in regions with a warm, humid
climate and/or in an agricultural economy(1). Studies from different continents
identified fungi in 6% to 53% of cases of suppurative keratitis(2-3). Filamen-
tous fungi are responsible for the majority of these cases(4). Höfling-Lima et
al.(5) cited filamentous fungi as responsible for 79% of fungal keratitis and
showed that the genus Fusarium is responsible for 59% of the fungal ke-
ratitis in patients of the Federal University of São Paulo.
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The key elements in successful treatment of this condition
in a manner which spares vision are early diagnosis, timely
identification of the pathogen, and application of effective
antifungal drugs. While early diagnosis and identification of
pathogens is generally straightforward, the therapy for fungal
keratitis is restricted by a limited choice of effective antifungal
drugs for topical administration.
The polyene, natamycin (pimaricin), has been recommended
at a concentration of 5% as the topical drug of choice for first
line treatment of filamentous fungal keratitis(6-7). In recent years,
azole compounds have demonstrated promise in the treatment
of fungal keratitis. Prajna et al.(8) reported that a 2% preparation
of econazole for topical application was as effective as 5%
natamycin in the management of filamentous fungal keratitis.
Kalavathy et al.(9) compared topical 1% itraconazole with 5%
natamycin and reported that natamycin should continue to be
the treatment of choice for filamentous fungal keratitis. Ho-
wever, in many developing nations, natamycin and azole com-
pounds are not readily available or affordable.
Povidone-iodine has been used for many years as an effec-
tive broad-spectrum disinfectant in ophthalmic surgeries(10).
The solution is inexpensive and widely available. Povidone-
iodine is a complex of polyvinylpyrrolidone and iodine. Its
chemistry is only partially understood and has been subject of
several reviews. Several studies have demonstrated its effec-
tiveness against bacteria(11). It is also effective against viruses
and fungi(2).
We sought to evaluate the potential clinical efficacy of to-
pical 0.5% povidone-iodine eyedrop preparation by comparing it
with a standard therapeutic regimen with topical 5% natamycin
for Fusarium solani fungal keratitis in a rabbit model.
METHODS
We performed an experimental, randomized, controlled
study in a rabbit model. Permission for the experimental study
was obtained from the Ethics Committee of the Federal Uni-
versity of São Paulo, and we strictly adhered to the experimen-
tal rules set forth in the ARVO resolution on animal experi-
mentation.
A strain of Fusarium solani (IMI 314228, International
Mycological Institute, Surrey, UK) was grown on potato-
dextrose agar slants at 35°C for the first 48 hours and at 25°C
until day 7. The formed colonies were covered with 2 mL sterile
0.9% saline, and suspended by gently probing them with the
tip of a Pasteur pipette. The resulting mixture of conidia, hy-
phal fragments and agar particles was transferred to a sterile
test tube. Heavy particles were allowed to settle for 5 minutes,
and the upper homogeneous suspension was collected with a
micropipette, transferred to another tube and mixed in a vortex
for 15 seconds. The density of the conidial suspension was
read in a spectrophotometer and adjusted to an optical densi-
ty range of 0.15 to 0.17, which corresponds to 0.4 x 106 to 0.5x
106 CFU/mL. Inoculum size was also checked by plating 10 μL
of a 1:100 dilution of the suspension on Sabouraud agar plates
and by counting the conidia in a Neubauer chamber.
We induced Fusarium solani keratitis in the right eye of 24
adult male New Zealand rabbits (1.4-2.6 kg in weight). Prior to
the inoculation, the eyes received 5 daily subconjunctival
injections of 0.2 mL 0.4% dexamethasone sodium phosphate,
under topical anesthesia (proparacaine). Inoculation was per-
formed on the last day of this preparation.
Animals were anesthetized with intramuscular ketamine hy-
drochloride (35-50 mg/kg), xylazine hydrochloride (5-7.5 mg/kg),
and with topical 0.5% proparacaine hydrochloride drops.
Under the operating microscope, the eye was gently propto-
sed and fixated. A temporal vertical incision, 2 mm in width
and 250 μm in depth, was made 2 mm from the center of the
cornea with a diamond knife. The blunt needle of a micro-
syringe (model 80300, Hamilton Company, Reno, NV, USA)
was advanced through the previous incision and 10 μL of the
inoculum were injected into the corneal stroma. Five days after
inoculation, we verified the presence of a corneal infiltrate
(Figure 1) (infiltrate ≥ 2 mm), and we divided the animals ran-
domly into 3 treatment groups: Gr.I: treated with topical 0.5%
povidone-iodine hourly (7am - 11pm) for three days; Gr.II:
treated with topical 5% natamycin hourly (7am - 11pm) for
three days; and Gr.III: treated with topical normal saline
hourly (7am - 11pm) for three days (control). All animals un-
derwent corneal scraping for debridement of the epithelium
and necrotic tissue overlying the infiltrate to allow for better
penetration of the topical antimicrobial drops before initiating
the treatment. The three different drugs were prepared under
sterile conditions by the same pharmaceutical company (Oph-
talmos Fórmulas Oficinais Ltda., São Paulo, Brasil) using iden-
tical diluents. There were no preservatives in any of the three
preparations. Prophylactic moxifloxacin (Vigamox®, Alcon,
Fort Worth, TX, USA) drops were used every 6 hours on the
right eye of all animals. During the treatment, we evaluated the
rabbits daily with the slit lamp, and clinical features were
scored. We considered the size and depth of the infiltrate, the
Figure 1 - Infected rabbit. 2 mm x 2.5 mm central corneal infiltrate with
hypopyon in the anterior chamber.
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growth of new vessels into the cornea, conjunctival injection,
hypopyon, and discharge.
The day after conclusion of the treatment period, all rab-
bits were anesthetized with intramuscular ketamine hydroch-
loride (35-50 mg/kg) and xylazine hydrochloride (5-7.5 mg/kg),
and were sacrificed with intravenous sodium pentobarbital
(150 mg/kg). The right cornea of each animal was trephined,
thoroughly washed with sterile balanced salt solution, mace-
rated, and immersed in 10 mL BHI with gentamicin (50 mg/L)
and chloramphenicol (40 mg/L). All surgical instruments were
utilized on a single use base to avoid cross contamination.
Immediately after incubation, the test tubes contents were
homogenized for 15 seconds and allowed to settle for 15
minutes. These solutions were diluted to 1/10 and to 1/100. A
10 μL aliquot of the upper homogeneous suspension of each
solution and its dilutions were plated on Sabouraud’s agar
and kept at 25°C. This procedure was repeated every 24 hours
for 7 days. The number of CFU was counted for 5 days after
each seeding (total of seven seeding days). We established
100 CFU as the maximum growth. We considered days 1, 4, and
7 of seeding for analyzing the CFU at the standard solution
and 1/10 diluted solution. For the 1/100 diluted solution, we
considered days 1 and 7 of seeding. The comparisons of CFU
counts for the three study groups were performed using the
Kruskal-Wallis test.
RESULTS
We found no statistically significant difference in clinical
appearance between the three groups after treatment. All
groups had clinically indistinguishable disease during the
treatment period and on the day of sacrifice.
Groups I and II, 0.5% povidone-iodine and 5% natamycin
respectively, demonstrated better efficacy than Gr. III (control)
when comparing the number of rabbits in which there were no
colonies growing. Four rabbits in Gr.I, 5 rabbits in Gr.II, and 3
rabbits in Gr.III demonstrated no colony growth. However, the
confidence intervals between the three groups overlapped,
suggesting that there was no statistically significant difference
between them (Graph 1).
On days 1, 4, and 7 after incubation in BHI, samples were
plated on Sabouraud agar and were counted on days 1 through
5. The standard solution (Table 1) and the 1/10 diluted solution
(data not shown) demonstrated no statistical difference in the
number of CFU between the 3 groups. Likewise, the 1/100
diluted solution demonstrated no statistical difference on days
1 and 7 after incubation in BHI, considering counting days 1
through 5 (Table 1).
DISCUSSION
Povidone-iodine has a broad spectrum of action, is cost
effective, and has been used for preoperative antibiotic pro-
phylaxis(10). Its efficacy against Fusarium solani has been
demonstrated in vitro by Martin et al.(2), as well as in vivo(12).
White et al.(12) reported that 1% povidone-iodine led to a
significant reduction in the duration of experimentally induced
disease with Aspergillus niger, in rabbits, without notable
irritation. Because of its effectiveness against filamentous
fungi in vitro as well as in vivo, we evaluated its benefits in a
rabbit model of Fusarium solani keratitis.
Our study demonstrated no clinical difference between the
three groups during the treatment period. It is possible that
subconjunctival injection of corticosteroids may have partial-
ly suppressed the ocular inflammation and the rabbits got
infected in such a similar situation, that no difference in
clinical response could be determined during the three treat-
ment days. Fiscella et al.(13) reported the same lack of differen-
ce in clinical features for 10 days after corticosteroid adminis-
tration in an experimental Fusarium keratomycosis. O’Day et
al.(14) noted that the use of glucocorticoids, usually given
subconjunctivally, alters the course of disease and facilitates
the establishment of infection. When corticoids are given, the
fungal burden remains stable longer and the inflammatory
response in the cornea is worsened(15). It is also noted that the
usual effective duration of this rabbit model of filamentous
keratitis is about 5-10 days(14,16). Moreover, three days of
clinical evaluation is a very short period of time to discern
significant clinical differences between the groups when
dealing with fungal infection. On the other hand, this finding
suggests that the methodology used to infect the animals
worked similarly in all groups. Evaluation of clinical scores
was, therefore, not considered a reliable measure of active
infection in this study.
There was no statistical significance when we compared
the number of rabbits in which there were no colonies gro-
wing. The confidence intervals between the three groups over-
lapped. If we assume repeatability of the point estimates, a
calculation would give an appropriate sample size for future
experiments. However, we did not have a normal distribution
in our study, and consequently, it is difficult to determine the
adequate sample size for future experiments. It is impressive
that in 3 rabbits in the control group the infection resolved
with no treatment. This reflects the strong inflammatory res-
Graph 1 - Confidence intervals for the three treatment groups of fungal
keratitis due to Fusarium solani (intervals at 95% confidence level)
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Table 1. Number of colony-forming units according to the study group at a dilution of 1/100 and the standard solution
Days in Petri dish
1 Day 2 Days 3 Days 4 Days 5 Days
Incubation CFU CFU CFU CFU CFU
time in Group Median Median Median Median Median
BHI (min-max) P  (min-max) P  (min-max) P  (min-max) P  (min-max) P
SS 1 Day Control 0 (0-0) 1.00 0 (0-0) 1.00 0 (0-0) 1.00 0 (0-0) 1.00 0 (0-0) 1.00
Povidone 0 (0-0) 0 (0-0) 0 (0-0) 0 (0-0) 0 (0-0)
Natamycin 0 (0-0) 0 (0-0) 0 (0-0) 0 (0-0) 0 (0-0)
SS 4 Days Control 10 (0-38) 0.38 64.5 (0->100) 0.62 69.5 (0->100) 0.73 72.5 (0->100) 0.65 72.5 (0->100) 0.65
Povidone 0 (0-49) 0 (0->100) 0 (0->100) 0 (0->100) 0 (0->100)
Natamycin 0 (0-86) 0 (0->100) 0 (0->100) 0 (0->100) 0 (0->100)
SS 7 Days Control 3 (0-18) 0.53 >100 (0->100) 0.70 >100 (0->100) 0.70 >100 (0->100) 0.79 >100 (0->100) 0.79
Povidone 0 (0-13) 50 (0->100) 50 (0->100) 50 (0->100) 50 (0->100)
Natamycin 0 (0-12) 0 (0->100) 0 (0->100) 1 (0->100) 1 (0->100)
1/100 1 Day Control 0 (0-0) 1.00 0 (0-0) 1.00 0 (0-0) 1.00 0 (0-0) 1.00 0 (0-0) 1.00
Povidone 0 (0-0) 0 (0-0) 0 (0-0) 0 (0-0) 0 (0-0)
Natamycin 0 (0-0) 0 (0-0) 0 (0-0) 0 (0-0) 0 (0-0)
1/100 7 Days Control 0 (0-0) 0.89 9 (0-19) 0.77 11 (0-24) 0.75 11.5 (0-24) 0.75 11.5 (0-24) 0.77
Povidone 0 (0-0) 0.5 (0-15) 0.5 (0-20) 0.5 (0-20) 0.5 (0-20)
Natamycin 0 (0-5) 0 (0->100) 0 (0->100) 0 (0->100) 0 (0->100)
BHI= brain heart infusion; CFU= colony-forming unit; min= minimum; max= maximum; SS= standard solution; 1/100= 1/100 dilution
ponse presented by rabbits to infectious agents. In some
cases demonstrating healing in a period of time up to 8 days
after inoculation, even with subconjunctival corticosteroid
administration previous to inoculation(17).
Another limitation in our study was fixing the maximum
number of CFU at 100. We used that number since in our
previous pilot study, the colonies were confluent and be-
came somewhat indistinct one from another. Preestablishing
that number fixed the limit for statistical analysis for all
groups; in some cases the CFU would clearly be higher than
that, if it had been possible to count the colonies further. For
example, when we observe the control group on the 7th day of
incubation in BHI, and on the 2nd day of colony counting, the
number of colonies was higher than 100 (Table 1). It is
evident that this number would be higher than that on the 5th
day of colony counting. Establishing 100 CFU as the maxi-
mum limit for all groups rendered the statistical analysis
limited. We recognized the problem with counting more than
100 colonies per plate in previous pilot studies. An alter-
native solution was to dilute the standard solution to 1/10
and 1/100. However, analyzing diluted solutions did not de-
monstrate statistical significance between the groups in any
of the evaluated incubation and counting days. We plated
the standard solutions and dilutions on different plating
days (days 1, 4, and 7 for standard solution and the 1/10
diluted solution; and days 1 and 7 for the 1/100 diluted
solution). None demonstrated statistical significance. Ho-
wever, it is clear that the CFU are higher with longer incu-
bation in BHI. For future studies we recommend fixing the
number of days in BHI, fixing the dilution level, and the
number of counting days in the Petri dish. It seems reaso-
nable to choose the 7th day in BHI and to observe the respon-
se on the 5th day in the Petri dish in order to allow full
opportunity for colony growth. The methodology of coun-
ting colony forming units or any quantitative isolate reco-
very technique should be taken into consideration when mea-
suring responses to therapy in keratomycosis. More sen-
sitive and specific measures are clearly needed.
Toxicity was not evaluated in our study. According to
York et al., concentrations of 0.5% topical PVP-I or less (6 to 8
times daily) are practically non-irritating and might delay
epithelial healing in one day(18).
With the above mentioned limitations, our results do not
suggest that topical 0.5% povidone-iodine is efficacious for
the treatment of Fusarium solani keratitis. However, one
cannot conclude from this study that the treatment modalities
are equivalent. According to recently published data in the
literature, topical natamycin continues to be considered the
therapy of choice for treatment of filamentous keratitis(9). Al-
fonso(19) reviewed cases of Fusarium keratitis at the Bascom
Palmer Eye Institute, University of Miami, in a recent contact
lens related outbreak of this disease in the United States.
Topical 5% natamycin was used in 91% of the patients. Newer
antifungal agents such as voriconazole were promising in
both in vitro susceptibility testing against ocular fungal iso-
lates and in clinical settings(20). However, comparative clinical
trials are necessary to prove superior efficacy and safety in
order to recommend voriconazole over natamycin as topical
agent for Fusarium keratitis.
Using this methodology of counting colony-forming units
and with this sample size, topical 0.5% povidone-iodine de-
monstrated no significant benefit in the treatment of experi-
mental Fusarium solani fungal keratitis when compared with
topical 5% natamycin. It will be valuable to enlarge the sample
size and to adjust the methodology in order to allow for a
better evaluation of these drugs. The present study demons-
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trates important methodological considerations in the use of
in vivo animal models to test the effectiveness of antifungal
agents. Larger numbers and alterations in the quantitative
microbiology may yet demonstrate the antifungal efficacy of
these agents.
RESUMO
Objetivo: Avaliar a eficácia do uso tópico de iodo-povidona
0,5% em ceratite experimental por Fusarium solani em coe-
lhos. Métodos: Ceratite fúngica por Fusarium solani foi
induzida no olho direito de 24 coelhos da raça New Zealand.
Os coelhos foram divididos aleatoriamente em 3 diferentes
grupos de tratamento: Grupo I (iodo-povidona) - tratados
com iodo-povidona 0,5%; Grupo II (natamicina) - tratados
com natamicina 5%; Grupo III (controle) - tratados com solu-
ção salina. Os coelhos dos 3 grupos foram tratados por 3
dias e sacrificados em seguida. As córneas foram removidas
cirurgicamente, maceradas e incubadas em meio BHI. Se-
meou-se culturas em placas de ágar Sabouraud, diariamente,
durante 7 dias, e contou-se o número de unidades formado-
ras de colônias (UFC). Os coelhos foram avaliados clinica-
mente durante o período de tratamento. Resultados: Os gru-
pos iodo-povidona e natamicina demonstraram melhor eficá-
cia do que o grupo controle considerando-se o número de
coelhos nos quais não houve crescimento de colônias. En-
tretanto, não houve diferença estatística significante entre
os 3 grupos quando se analizou o número de UFC (p>0,05).
Conclusão: Este estudo demonstrou considerações metodo-
lógicas importantes na utilização de modelos animais para o
teste de agentes antifúngicos. Usando a metodologia de
contar UFC e com este tamanho amostral, administração tó-
pica de iodo-povidona 0,5% não demonstrou benefício do
tratamento de ceratite fúngica experimental causada por Fu-
sarium solani quando comparado com a administração tópi-
ca de natamicina 5%.
Descritores: Ceratite/microbiologia; Povidona-Iodo/adminis-
tração & dosagem; Povidona-Iodo/uso terapêutico; Fusa-
rium; Natamicina/administração & dosagem; Natamicina/uso
terapêutico; Infecções oculares fúngicas/quimioterapia; Anti-
micóticos/administração & dosagem; Antimicóticos/uso tera-
pêutico.
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